{"id":"https://genegraph.clinicalgenome.org/r/be010aff-fedb-44d8-8491-904104a9049cv1.0","type":"EvidenceStrengthAssertion","dc:description":"The relationship between ETHE1 and Leigh syndrome spectrum was evaluated using the ClinGen Clinical Validity Framework as of December 10, 2018. 34 articles were reviewed. ETHE1 was first reported in association with ethylmalonic encephalopathy in 2004 (Tiranti et al., PMID 14732903) and first associated Leigh syndrome spectrum in 2006 (Herberle et al., PMID 16376514). At least 39 unique variants predicted to cause a loss of or reduced function of the protein have been reported in ClinVar, suggesting homozygous loss of function is the mechanism of disease for this gene. Evidence supporting this gene-disease relationship includes case-level data and experimental data. Variants in this gene have been reported in at least 7 probands with Leigh syndrome spectrum in 7 publications (PMID: 18593870, 20978941, 20528888, 27830356, 26917598, 16376514). This gene-disease association is supported by expression, animal model, and rescue experiments. As previously stated, this gene has been primarily associated with ethylmalonic encephalopathy (progressive disorder characterized by mutisystem involvement including chronic diarrhea, developmental delay, petechiae, and acrocyanosis). This phenotype will be assessed separately. In summary, there is definitive evidence to support the relationship between ETHE1 and autosomal recessive Leigh syndrome spectrum. More than three years have elapsed from the first proposal of the association to reach a definitive classification. This classification was approved by the NICHD U24 ClinGen Mitochondrial Disease Gene Curation Expert Panel on December 10, 2018 (SOP Version 6).","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/be010aff-fedb-44d8-8491-904104a9049c","GCISnapshot":"https://genegraph.clinicalgenome.org/r/d29d908d-ea85-4eb4-a6a5-400c95511c9a","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/d29d908d-ea85-4eb4-a6a5-400c95511c9a_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10027","date":"2019-04-08T16:17:59.443Z","role":"Approver"},{"id":"https://genegraph.clinicalgenome.org/r/d29d908d-ea85-4eb4-a6a5-400c95511c9a_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10027","date":"2020-09-01T00:00:00Z","role":"Publisher"}],"curationReasonDescription":"","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d29d908d-ea85-4eb4-a6a5-400c95511c9a_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d29d908d-ea85-4eb4-a6a5-400c95511c9a_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8d187f90-8018-4677-b589-aba361224b71","type":"EvidenceLine","dc:description":"Utilized model scoring system developed for Leigh syndrome experimental evidence","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/187b6190-d43a-44cf-a169-541aeba21c2a","type":"Finding","dc:description":"Model system demonstrated biochemical abnormalities consisted with Leigh syndrome (lactic acidemia and reduced COX activity) along with neurocognitive and developmental symptoms (Reduced motor activity and wide based gait).","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19136963","rdfs:label":"ETHE1 Knockout Mouse Model","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/a01bcaae-387b-4f36-9af6-85f53a3dc0f5","type":"EvidenceLine","dc:description":"Partial rescue of biochemical phenotype of ETHE1 knock out mouse.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/02be9289-3edc-42a8-8b31-c0f4c48a105d","type":"Finding","dc:description":"AAV of wild type ETHE1 partially rescued ETHE1 mouse knock out phenotype. There was a partial resoration of cytochrome oxidase activity in muscle and brain.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28753212","rdfs:label":"ETHE1 K/O mouse rescue","demonstrates":{"id":"cg:PhenotypeRescue"}}],"specifiedBy":"GeneValidityNonHumanRescueCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":2.5},{"id":"https://genegraph.clinicalgenome.org/r/d29d908d-ea85-4eb4-a6a5-400c95511c9a_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/24651e94-ecb4-4cd5-ac3b-35e5fa026a86","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f0f52f62-6d20-43f3-9f46-ae20c326696e","type":"Finding","dc:description":"The Human Protein Atlas Atlas (Uhlen et al 2015; PMID: 25613900) demonstrates that ETHE1 protein is ubiquitously expressed (https://www.proteinatlas.org/ENSG00000105755-ETHE1/tissue).  Expression in the brain has been shown in the cerebral cortex, caudate, and cerebellum. Points can be awarded as this expression profile is consistent with areas of pathology in Leigh-like syndrome.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25613900","rdfs:label":"Human Atlas brain expression","demonstrates":{"id":"cg:GeneExpressionA"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":3},{"id":"https://genegraph.clinicalgenome.org/r/d29d908d-ea85-4eb4-a6a5-400c95511c9a_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/20e4c865-c8f7-4730-a4e3-4f75043c3ef3_proband_score_evidence_line","type":"EvidenceLine","dc:description":"This deletion is considered the ETHE1 common pathogenic mutation. It has been described in multiple affected patients.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b2441426-acdf-4587-92b4-02e8bb200ee6","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20978941","rdfs:label":"Patient 3 (Barth)","ageType":"AgeAtOnset","ageUnit":"Months","ageValue":2,"detectionMethod":"qRT-PCR for deletion detection","firstTestingMethod":"PCR","phenotypeFreeText":"Brain MRI: Symmetric patchy high T2-weighted areas in caudate nuclei and thalami with global brain atrophy.\nCytochrome oxidase deficiency noted in fibroblasts ~ 50% of normal","phenotypes":["obo:HP_0012707","obo:HP_0003219","obo:HP_0002376","obo:HP_0000967","obo:HP_0030085","obo:HP_0001290","obo:HP_0001508","obo:HP_0002151","obo:HP_0002028","obo:HP_0002339","obo:HP_0011968","obo:HP_0001063"],"previousTesting":true,"previousTestingDescription":"Sanger sequencing of all 7 exons of ETHE1","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/20e4c865-c8f7-4730-a4e3-4f75043c3ef3_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20978941","allele":{"id":"https://genegraph.clinicalgenome.org/r/10f64e4f-09ac-474d-afb3-662698b5dd1c","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"ETHE1, EX4DEL","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/2323"}}}}],"specifiedBy":"GeneValidityProbandARDeNovoNullVariantCriteria","strengthScore":3},{"id":"https://genegraph.clinicalgenome.org/r/99b498f6-c5b3-4db1-9db6-f1a39b7be362_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Western blot shows reduced ETHE1 expression","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/64505a2c-c40c-44db-a9fc-3a732a19bff9","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18593870","rdfs:label":"Patient 3 (Mineri)","ageType":"AgeAtOnset","ageUnit":"Months","ageValue":6,"detectionMethod":"Sanger sequencing of all 7 exons of ETHE1","firstTestingMethod":"Sanger sequencing","phenotypeFreeText":"Additionally, patient demonstrated Abnormal signal in the white matter with Leigh-like lesions on MRI and reduced Cytochrome Oxidase deficiency on muscle bx (30% of control)","phenotypes":["obo:HP_0001290","obo:HP_0003219","obo:HP_0001063","obo:HP_0001250","obo:HP_0000967","obo:HP_0002376"],"previousTesting":false,"previousTestingDescription":"","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/99b498f6-c5b3-4db1-9db6-f1a39b7be362_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18593870","allele":{"id":"https://genegraph.clinicalgenome.org/r/520cba85-96d2-427a-855e-59e245578d6b","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_014297.4(ETHE1):c.164T>C (p.Leu55Pro)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/504494"}}}}],"specifiedBy":"GeneValidityProbandARNonNullCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/5fde1c67-22ac-4d85-bd4d-48e603fda47e_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Western blots of fibroblasts demonstrated absence of ETHE1 protein","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/42cdbdc3-596c-412f-a775-189d9168fdf8","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27830356","rdfs:label":"Index (Kilic)","ageType":"AgeAtOnset","ageUnit":"Months","ageValue":10,"detectionMethod":"Direct sequencing of ETHE1 gene revealed a homozygous c.554 T > G; p. L185R mutation in exon 5.","firstTestingMethod":"Sanger sequencing","phenotypeFreeText":"Patient's MRI demonstrated abnormal lesions on corpus striatum and middle cerebellar peduncle bilaterally.","phenotypes":["obo:HP_0000967","obo:HP_0002151","obo:HP_0011968","obo:HP_0002376","obo:HP_0012707","obo:HP_0001063","obo:HP_0003219","obo:HP_0000252","obo:HP_0001290"],"previousTesting":false,"previousTestingDescription":"","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/5fde1c67-22ac-4d85-bd4d-48e603fda47e_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27830356","allele":{"id":"https://genegraph.clinicalgenome.org/r/dc1db1cc-94c4-4c12-a48d-5ed2c713bf73","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_014297.4(ETHE1):c.554T>G (p.Leu185Arg)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/30725"}}}}],"specifiedBy":"GeneValidityProbandARDeNovoNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/be865804-dfdc-4b5b-a869-cd261c125e18_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Western blot data shows no ETHE1 expression","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/fd4253c4-f3d4-4bed-815c-3f71c3244b3a","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20528888","rdfs:label":"Patient 1 (Drousiotou)","ageType":"AgeAtOnset","ageUnit":"Months","ageValue":2,"detectionMethod":"Sanger sequencing of all 7 exons of ETHE1 and qRT-PCR for deletion detection","firstTestingMethod":"Sanger sequencing","phenotypeFreeText":"Patient's brain MRI demonstrated Multiple loci of high intensity on the T2-weighted images and low-signal intensity on the Flair and T1W/SE images of the basal ganglia bilaterally. Muscle Biopsy showed reduced cytrochrome oxidase deficiency (8% of control).","phenotypes":["obo:HP_0002151","obo:HP_0001508","obo:HP_0002376","obo:HP_0001250","obo:HP_0000967","obo:HP_0001063","obo:HP_0003219","obo:HP_0007039","obo:HP_0002028","obo:HP_0031364","obo:HP_0000252","obo:HP_0011968"],"previousTesting":false,"previousTestingDescription":"","secondTestingMethod":"PCR","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/be865804-dfdc-4b5b-a869-cd261c125e18_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20528888","allele":[{"id":"https://genegraph.clinicalgenome.org/r/dc1db1cc-94c4-4c12-a48d-5ed2c713bf73"},{"id":"https://genegraph.clinicalgenome.org/r/10f64e4f-09ac-474d-afb3-662698b5dd1c"}]}}],"specifiedBy":"GeneValidityProbandARDeNovoNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/7b1d240c-c26b-4716-a498-22b535a63e73_proband_score_evidence_line","type":"EvidenceLine","dc:description":"deletion affecting nucleotide position 230 (230 delA) causes a frame shift at amino acid position 77 with the creation of a stop codon downstream (N77fsX144).","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2176ec1e-a3c5-4061-a0f4-0e707f54db8c","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16376514","rdfs:label":"Case 1 (Herberle)","ageType":"AgeAtOnset","ageUnit":"Months","ageValue":4,"detectionMethod":"","firstTestingMethod":"Sanger sequencing","phenotypeFreeText":"Brain MRI showed multiple areas of low and high signal (T1W & T2W) in the basal ganglia and prominent frontal and temporal subarachnoid spaces.","phenotypes":["obo:HP_0003219","obo:HP_0002028","obo:HP_0001508","obo:HP_0000028","obo:HP_0001290","obo:HP_0002151","obo:HP_0002376","obo:HP_0000967","obo:HP_0000252","obo:HP_0002240"],"previousTesting":false,"previousTestingDescription":"","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/7b1d240c-c26b-4716-a498-22b535a63e73_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16376514","allele":{"id":"https://genegraph.clinicalgenome.org/r/fb39c434-b588-4c6d-b864-7cb60c59edf3","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_014297.4(ETHE1):c.230delA (p.Asn77Ilefs)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/504497"}}}}],"specifiedBy":"GeneValidityProbandARDeNovoNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/4fcad9be-c8c9-4c5a-b09a-4b7924e43c29_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/98c59e63-efa1-4e9a-ae97-6f877ea89e77","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25878756","rdfs:label":"Index Case (Uluc)","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":4,"detectionMethod":"","firstTestingMethod":"Sanger sequencing","phenotypeFreeText":"Brain MRI showed bilateral punctuate hyperintense T2 signals in the basal ganglia with minor lactate peak on spectroscopy.","phenotypes":["obo:HP_0040083","obo:HP_0003487","obo:HP_0002172","obo:HP_0002151","obo:HP_0003219","obo:HP_0000565","obo:HP_0012378","obo:HP_0002376","obo:HP_0001347","obo:HP_0001063","obo:HP_0002169","obo:HP_0001263","obo:HP_0012707"],"previousTesting":false,"previousTestingDescription":"","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/4fcad9be-c8c9-4c5a-b09a-4b7924e43c29_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25878756","allele":{"id":"https://genegraph.clinicalgenome.org/r/157249ee-caa2-4a9b-bf10-5417d0d77293","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_014297.4(ETHE1):c.3G>T","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/2318"}}}}],"specifiedBy":"GeneValidityProbandARNonNullCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/43695b9c-93bf-4d7c-950e-4a87ede59747_proband_score_evidence_line","type":"EvidenceLine","dc:description":"c.131-132delAG mutation causes the formation of a premature stop codon. Western blot showed no ETHE1 expression","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1b32babe-4eae-4c2d-8194-feb7884071ef","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26917598","rdfs:label":"Index case (Dionisi-Vici)","ageType":"AgeAtOnset","ageUnit":"Months","ageValue":7,"detectionMethod":"Molecular genetic analysis of ETHE1 from blood DNA revealed the presence of a homozygous mutation c.131-132delAG which causes the formation of a premature stop codon","firstTestingMethod":"Sanger sequencing","phenotypeFreeText":"Patient's brain MRI showed involvement of basal ganglia, fronto-temporal atrophy with hyper-intense lesions involving bilaterally the putamen and caudate nucleus.","phenotypes":["obo:HP_0001063","obo:HP_0007039","obo:HP_0002339","obo:HP_0002376","obo:HP_0003219","obo:HP_0001290","obo:HP_0002151","obo:HP_0000967"],"previousTesting":false,"previousTestingDescription":"","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/43695b9c-93bf-4d7c-950e-4a87ede59747_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26917598","allele":{"id":"https://genegraph.clinicalgenome.org/r/fd35ac10-6567-4dc2-bcce-2e6ed0c24c3e","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001165963.2(SCN1A):c.2946+19T>C","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/496117"}}}}],"specifiedBy":"GeneValidityProbandARDeNovoNullVariantCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12}],"evidenceStrength":"Definitive","sequence":238,"specifiedBy":"GeneValidityCriteria6","strengthScore":15,"subject":{"id":"https://genegraph.clinicalgenome.org/r/TtqvOXuGd8E","type":"GeneValidityProposition","disease":"obo:MONDO_0009723","gene":"hgnc:23287","modeOfInheritance":"obo:HP_0000007"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_d29d908d-ea85-4eb4-a6a5-400c95511c9a-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}